<ARTICLE> 5
<LEGEND>
This Schedule contains summary financial information extracted from the
condensed financial statements of Cytomedix, Inc. for the three months ended
March 31, 2000 (unaudited) and is qualified in its entirety by reference to such
financial statements.
</LEGEND>

                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-31-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                       7,388,239
<SECURITIES>                                         0
<RECEIVABLES>                                  106,581
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             7,495,320
<PP&E>                                         212,897
<DEPRECIATION>                                 (9,614)
<TOTAL-ASSETS>                               7,713,104
<CURRENT-LIABILITIES>                          496,722
<BONDS>                                         91,349
<PREFERRED-MANDATORY>                        1,625,000
<PREFERRED>                                        570
<COMMON>                                         1,053
<OTHER-SE>                                   5,498,410
<TOTAL-LIABILITY-AND-EQUITY>                 7,713,104
<SALES>                                         34,504
<TOTAL-REVENUES>                                34,504
<CGS>                                            5,236
<TOTAL-COSTS>                                    5,236
<OTHER-EXPENSES>                             6,517,467
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,692
<INCOME-PRETAX>                            (6,471,096)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (6,471,096)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (6,491,408)
<EPS-BASIC>                                   (0.69)
<EPS-DILUTED>                                   (0.69)